Applications

1672 – Procedures for the insertion or removal of a leadless permanent pacemaker for the treatment of bradyarrhythmia

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation Closed
  • Pre-MSAC consultation Closed
  • Outcome Supported

Application details

Reason for application

New MBS item.

Service or technology in this application

The Micra Transcatheter Pacing System (TPS) is a type of leadless pacemaker, that is a single-chamber implantable transcatheter pacemaker inserted via the femoral vein and implanted directly into the right ventricular myocardium negating the need for transvenous wires.

Type: Therapeutic technology

Medical condition this application addresses

Bradycardia is defined as abnormally slow heart rhythm, as a consequence of the disturbance of the generation or conduction of cardiac electrical activity. Permanent pacing works by preventing the heart from beating slower than a predefined rate, by delivering an electrical stimulus to the myocardium when required.

Consultation survey and deadlines

  • PASC consultation: Closed
  • MSAC consultation: Closed Friday 10 June 2022

Meetings to consider this application

  • PASC meeting: 12 to 13 August 2021
  • ESC meeting: 9 to 10 June 2022
  • MSAC meeting: 28 to 29 July 2022